Merck & Co at a Crossroads with the Next Warfarin Heart Drug
Vorapaxar, Merck & Co’s latest heart medication is not good enough for patients and may be very bad for Merck.
Read moreVorapaxar, Merck & Co’s latest heart medication is not good enough for patients and may be very bad for Merck.
Read more